Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Takeda Pharmaceutical presents EIT6 inhibitors

Oct. 13, 2016

Xenetic Biosciences reports positive data from phase II trial of erepoxen

Oct. 11, 2016

JW Pharmaceutical reports desfesoterodine derivatives

Oct. 10, 2016

Toray Industries prepares and tests agents for urinary incontinence

Oct. 6, 2016

FDA grants orphan drug designation to AbbVie's atrasentan

Oct. 5, 2016

Dimerix reports positive safety data for phase II trial of DMX-200

Oct. 5, 2016

twoXAR collaborates with Mount Sinai researchers in diabetic nephropathy

Oct. 5, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent agents for nocturia

Sep. 23, 2016

Regulus begins phase II trial of RG-012 in Alport syndrome

Sep. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....